ArticleFrontiers in oncology2021

Peripheral Blood Autoantibodies Against to Tumor-Associated Antigen Predict Clinical Outcome to Immune Checkpoint Inhibitor-Based Treatment in Advanced Non-Small Cell Lung Cancer.

Juan Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.